GI Hormones and Their Functions

The gastrointestinal (GI) hormones are chemical messengers that orchestrate the complex process of digestion, ensuring nutrients are efficiently broken down and absorbed. For you as a pre-medical student, mastering these hormones is essential not only for human physiology but also for excelling on the MCAT, where questions often test your ability to integrate hormone function with clinical scenarios. A clear understanding of gastrin, secretin, cholecystokinin (CCK), glucose-dependent insulinotropic polypeptide (GIP), and motilin provides the foundation for diagnosing everything from peptic ulcers to malabsorption syndromes.

The Endocrine Orchestra of the Gut

Your digestive system relies on a precise hormonal coordination system that functions like a well-conducted orchestra. GI hormones are peptides released from specialized enteroendocrine cells in the mucosa of the stomach and intestines into the bloodstream. They travel to target organs to regulate secretory activity, motility, and growth. This endocrine control works in concert with neural signals to adapt digestive processes to the presence, type, and quantity of food. For the MCAT, you must view these hormones not in isolation but as an interactive network. A classic test strategy is to associate each hormone with its specific cell of origin, its primary physiological trigger, and its key target action—a triad often directly assessed in discrete questions and passage-based analyses.

Gastrin: The Prime Mover of Gastric Acid

Gastrin is the principal hormone regulating gastric acid secretion and is produced by G cells located primarily in the antrum of the stomach. Its release is stimulated by the presence of peptides and amino acids in the stomach, vagal stimulation, and gastric distention. Once released, gastrin enters the circulation and binds to receptors on parietal cells, directly stimulating them to secrete hydrochloric acid (HCl). Beyond acid secretion, gastrin is a crucial trophic hormone, promoting the growth and maintenance of the gastric mucosa.

A critical clinical correlation is Zollinger-Ellison syndrome, caused by a gastrin-secreting tumor (gastrinoma). Imagine a patient presenting with severe, recurrent peptic ulcers in atypical locations like the jejunum. This vignette should immediately cue you to suspect abnormally high gastrin levels leading to excessive acid production, overwhelming the duodenum's normal neutralizing capacity. On exams, a common trap is to associate gastrin with inhibition of acid; remember, it is the primary stimulator. Its action is self-limiting: as stomach pH drops below 3, the acidic environment inhibits further gastrin release, a key negative feedback loop.

Secretin and CCK: The Duodenal Duo

When acidic chyme enters the duodenum, two hormones are pivotal for neutralizing and digesting it: secretin and cholecystokinin. Secretin is released from S cells in the duodenum in response to a low duodenal pH (high acidity). Its primary mission is to protect the duodenal lining. It stimulates the pancreatic ductal cells to secrete a large volume of bicarbonate-rich fluid, which effectively neutralizes the gastric acid. Simultaneously, secretin inhibits gastric acid secretion and gastric motility, allowing time for neutralization and digestion.

Cholecystokinin (CCK) is secreted from I cells in the duodenum and jejunum, primarily in response to fats and peptides. CCK has two major actions: it stimulates the acinar cells of the pancreas to secrete digestive enzymes (e.g., lipases, proteases), and it causes contraction of the gallbladder while relaxing the sphincter of Oddi, thereby ejecting bile into the duodenum to emulsify fats.

For the MCAT, you must understand their synergistic and distinct roles. They are often released together but have different primary triggers: acid for secretin, fats for CCK. A test question might present a patient with gallstones (cholelithiasis) impairing bile flow. You should reason that this would lead to prolonged fat presence in the duodenum, causing sustained CCK release and potentially pancreatic enzyme secretion without adequate bile, affecting fat digestion. Conversely, in chronic pancreatitis, where bicarbonate secretion is impaired, secretin's role in managing duodenal pH becomes critically relevant.

GIP and Motilin: Regulators of Metabolism and Motility

Following nutrient absorption, two other hormones modulate metabolic response and fasted-state motility. Glucose-dependent insulinotropic polypeptide (GIP), secreted by K cells in the duodenum and jejunum, is part of the "incretin effect." It is released in response to oral glucose and fats. Its primary function is to stimulate insulin release from pancreatic beta cells in a glucose-dependent manner, meaning it potentiates insulin secretion only when blood glucose is elevated. This prepares tissues to store incoming nutrients and is a key reason why oral glucose elicits a greater insulin response than intravenous glucose.

Motilin operates during the fasting state between meals. It is released from M cells in the duodenum and jejunum during periods of low nutrient availability. Its key function is to initiate the migrating motor complex (MMC), a cyclical, propagating pattern of smooth muscle contractions that sweeps undigested material and debris from the stomach and small intestine toward the colon. This "housekeeping" wave prevents bacterial overgrowth and prepares the tract for the next meal.

In an exam context, confuse GIP with glucagon at your peril. GIP stimulates insulin, lowering blood glucose, whereas glucagon raises it. For motilin, a classic pitfall is associating it with fed-state motility; it is exclusively a fasting hormone. Erythromycin, an antibiotic, acts as a motilin receptor agonist and is sometimes used clinically to stimulate gastric emptying, a fact often tested in pharmacology-integrated physiology questions.

Common Pitfalls and Clinical Corrections

1. Confusing Hormone Sources: Mistaking which enteroendocrine cell produces which hormone is a frequent error. Use the mnemonic "Gets Seriously Cool, Kids Motivate" for G cells (Gastrin), S cells (Secretin), I cells (CCK), K cells (GIP), and M cells (Motilin). Remember, the letter often corresponds to the hormone's first letter or a key feature.

1. Mixing Up Primary Stimuli: It's easy to conflate the triggers for secretin and CCK. Correction: Think "Secretin for Stomach acid" (low pH). Think "CCK for Cholecystokinin and Cholesterol/fats." Secretin is for acid neutralization; CCK is for fat and protein digestion.

1. Incorrectly Assigning Insulin Effects: Assuming all GI hormones affect insulin is wrong. Correction: Only GIP (and GLP-1, not covered here) are considered true incretins that stimulate insulin release. Gastrin, secretin, and CCK do not have significant direct effects on insulin secretion.

1. Misunderstanding Motilin's Role: Believing motilin is involved in post-meal peristalsis. Correction: Fed-state motility is largely under neural control. Motilin-specific MMC activity occurs only during fasting, every 90-120 minutes, and ceases immediately upon eating.

Summary

• Gastrin (from G cells) is the main stimulator of gastric acid secretion and promotes gastric mucosal growth; its dysregulation is central to conditions like Zollinger-Ellison syndrome.
• Secretin (from S cells) is released by duodenal acid and drives pancreatic bicarbonate secretion to neutralize chyme, while also inhibiting further gastric acid production.
• Cholecystokinin (CCK) (from I cells) is triggered by fats and peptides, stimulating pancreatic enzyme secretion and gallbladder contraction to enable efficient fat digestion.
• Glucose-dependent Insulinotropic Polypeptide (GIP) (from K cells) responds to oral nutrients, primarily potentiating glucose-dependent insulin release, exemplifying the incretin effect.
• Motilin (from M cells) cycles during fasting to initiate the migrating motor complex, which clears the GI tract of residual content between meals.